Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
AZD-7687
/
AstraZeneca
Welcome,
Profile
Billing
Logout
11 Diseases
0 Trials
0 Trials
1 News
|
|||||||||
AZD-7687
/
AstraZeneca
Journal:
Evolving data analysis of an Oral Lipid Tolerance Test toward the standard for the Oral Glucose Tolerance Test: Cross species modeling effects of AZD7687 on plasma triacylglycerol.
(Pubmed Central) - May 29, 2019
Body mass index was found to be a significant covariate on the plasma TAG baseline. The system parameters of the model will facilitate analysis for other compounds and provide tools to bring the standard of OLTT data analysis closer to the analyses of Oral Glucose Tolerance Test data maximizing knowledge gain.